manual-prevencion

MANUAL SEOM DE PREVENCIÓN Y DIAGNÓSTICO PRECOZ DEL CÁNCER 95 interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol. 2010;28(27):4177–83. 27. Gonçalves DU, Proietti FA, Ribas JGR, Araújo MG, Pinheiro SR, Guedes AC, et al. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev. 2010;23(3):577–89. 28. Mager D. Bacteria and cancer: cause, coincidence or cure? A review. 29. Polk DB, Peek RM. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer [Internet]. 2010;10(6):403–14. Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-77952903266&partnerID=tZOtx3y1 30. Ishaq S, Nunn L. Helicobacter pylori and gastric cancer: A state of the art review. Gastroenterol Hepatol from Bed to Bench. 2015;8(6):S6–14. 31. Mitchell H, Katelaris P. Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection. Med J Aust [Internet]. 2016;204(10):376–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27256648 32. Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori Infection. Helicobacter. 2014;19(S1):1–5. 33. Lu B, Li M. Helicobacter pylori eradication for preventing gastric cancer. World J Gastroenterol. 2014;20(19):5660–5. 34.FordAC,FormanD,HuntRH,YuanY,MoayyediP.Helicobacterpylorieradicationtherapytopreventgastriccancerinhealthyasymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ [Internet]. 2014;348(May):g3174. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4027797&tool=pmcentrez&rendertype=abstract 35. van Tong H, Brindley PJ, Meyer CG, Velavan TP. Parasite Infection, Carcinogenesis and Human Malignancy. EBioMedicine [Internet]. 2016;15:12–23. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2352396416305515